JPMorgan analyst David Adlington lowered the firm’s price target on Medacta Group to CHF 93 from CHF 100 and keeps a Neutral rating on the shares.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MEDGF:
Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
